Saving Lives Globally vs. Defending Pharma Profits

Source: The American Prospect
by Robert Kuttner

“More than a year after Joe Biden announced his support for a waiver of intellectual-property rules to supply cheap vaccines to most of the world’s people, the process remains blocked. The European Union is still siding with the drug companies, and the U.S. has not followed through on Biden’s pledge. The issue comes to a head next week in Geneva, at the Ministerial Conference of World Trade Organization member nations beginning Sunday, June 12. Under the 1995 WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (known as TRIPS), countries that do not protect trademark, patent, and copyright rights of global corporations can face economically disabling sanctions. TRIPS, however, does allow countries to license local production of drugs in public-health emergencies.” (06/07/22)